AlphaMaven AlphaMaven

Hone Health Secures $228M for Longevity Platform

Reported by Dealbreaker
Nov 19, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Hone Health, a direct-to-consumer longevity platform, announced it has raised $228 million in financing to support its expansion.
  • • The funding comprises $28 million in equity as Series A financing and $200 million in growth financing from General Catalyst's Customer Value Fund.
  • • The round was led by MarcyPen Capital Partners, with participation from Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital and ID Ventures.
  • • Alongside the financing, Hone Health launched Hone Black, a concierge membership offering testing of more than 1,600 biomarkers and integrated hormonal, metabolic and cognitive care.
  • • The company says it has supported more than 200,000 patients and plans to use the capital for metabolic health, diagnostics, AI, a physician-supervised peptide program and clinical trials infrastructure.
Summary
Hone Health, a longevity platform, announced on Wednesday that it has raised $228 million in financing to support its expansion. The round includes $28 million in equity as Series A financing and $200 million in growth financing from General Catalyst's Customer Value Fund. MarcyPen Capital Partners led the financing, with participation from Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital and ID Ventures.

The direct-to-consumer company offers access to biomarker testing, physician consultations and personalized treatments, including for menopause, weight management, thyroid, heart health and sexual health. According to the announcement, Hone Health has supported more than 200,000 patients. Co-founder and CEO Saad Alam said that people have never had more data about their own bodies but little guidance on how to act on it, and that the company aims to provide the highest level of insight into metrics to support more informed health and longevity decisions.

According to the announcement, the funding will support five areas: launching and scaling programs for metabolic health, PMOS, inflammation and immunity; integrating diagnostic tools such as MRIs and gut microbiome testing into longitudinal patient care; improving its AI technology to help clinicians personalize care; launching a physician-supervised peptide program; and advancing clinical trials infrastructure.

Hone Health also launched Hone Black, a new membership that includes access to testing of more than 1,600 biomarkers, care across hormonal, metabolic and cognitive health, a concierge team and advanced treatments. The program had been in stealth for the last year. Alam described it as the company's most comprehensive concierge longevity membership to date. He added that Hone Health ultimately aims to build a research platform that improves health outcomes and helps people live longer. Gwyneth Paltrow, founder of Goop and a co-founder of Kinship Ventures, said wellness has become one of the biggest categories in the world and praised Hone's scientific approach and scale.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Dealbreaker Hone Health Secures $228M for Longevity Platform